FSRFX
Price
$107.12
Change
-$1.26 (-1.16%)
Updated
Jul 11 closing price
Net Assets
478.57M
RYPAX
Price
$51.54
Change
-$0.37 (-0.71%)
Updated
Jul 11 closing price
Net Assets
6.51M
Interact to see
Advertisement

FSRFX vs RYPAX

Header iconFSRFX vs RYPAX Comparison
Open Charts FSRFX vs RYPAXBanner chart's image
Fidelity Select Transportation
Price$107.12
Change-$1.26 (-1.16%)
VolumeN/A
Net Assets478.57M
Rydex Transportation H
Price$51.54
Change-$0.37 (-0.71%)
VolumeN/A
Net Assets6.51M
FSRFX vs RYPAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSRFX vs. RYPAX commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSRFX is a Buy and RYPAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSRFX has more cash in the bank: 479M vs. RYPAX (6.51M). FSRFX pays higher dividends than RYPAX: FSRFX (1.31) vs RYPAX (0.57). FSRFX was incepted earlier than RYPAX: FSRFX (39 years) vs RYPAX (27 years). RYPAX (1.68) is less costly to investors than FSRFX (0.69). RYPAX is a more actively managed with annual turnover of: 207.00 vs. FSRFX (22.00). FSRFX has a lower initial minimum investment than RYPAX: FSRFX (0) vs RYPAX (2500). RYPAX annual gain was more profitable for investors over the last year : 6.56 vs. FSRFX (1.55). FSRFX return over 5 years is better than : 57.14 vs. RYPAX (17.28).
FSRFXRYPAXFSRFX / RYPAX
Total Expense Ratio0.691.6542%
Annual Report Gross Expense Ratio0.691.6841%
Fund Existence39 years27 years-
Gain YTD4.6131.248370%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets479M6.51M7,362%
Annual Yield % from dividends1.310.57228%
Returns for 1 year1.556.5624%
Returns for 3 years27.094.02673%
Returns for 5 years57.1417.28331%
Returns for 10 years36.3119.19189%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMID38.262.67
+7.50%
Smith-Midland Corp
SUN53.530.80
+1.52%
Sunoco LP
PH714.910.61
+0.09%
Parker-Hannifin Corp
ANTX1.06-0.01
-0.93%
AN2 Therapeutics
REVG48.49-0.73
-1.48%
REV Group